BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31256218)

  • 21. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microscopic colitis in patients with ulcerative colitis or Crohn's disease: a retrospective observational study and review of the literature.
    Wickbom A; Bohr J; Nyhlin N; Eriksson A; Lapidus A; Münch A; Ung KA; Vigren L; Öst Å; Tysk C;
    Scand J Gastroenterol; 2018 Apr; 53(4):410-416. PubMed ID: 29546806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis.
    Zhu F; Feng D; Zhang T; Gu L; Zhu W; Guo Z; Li Y; Lu N; Gong J; Li N
    J Gastroenterol Hepatol; 2019 Jan; 34(1):154-161. PubMed ID: 29926959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
    Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.
    Lucendo AJ; Arias Á; Roncero Ó; Hervías D; Verdejo C; Naveas-Polo C; Bouhmidi A; Lorente R; Alcázar LM; Salueña I; García-Quiñones JA; Carrillo-Ramos MJ
    Dig Liver Dis; 2017 Apr; 49(4):405-411. PubMed ID: 28096058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
    Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
    BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
    Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
    Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
    World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
    Colombel JF; Jharap B; Sandborn WJ; Feagan B; Peyrin-Biroulet L; Eichner SF; Robinson AM; Mostafa NM; Zhou Q; Thakkar RB
    Aliment Pharmacol Ther; 2017 Jan; 45(1):50-62. PubMed ID: 27883215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
    Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
    J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
    Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
    J Clin Gastroenterol; 2016 Sep; 50(8):638-43. PubMed ID: 26485103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.